Derek Gumm is a transactional tax associate in the San Francisco office of Latham & Watkins.

Mr. Gumm advises US and non-US corporations, private equity funds, and investment banks in a variety of US and international contexts and specifically on federal tax issues related to mergers, acquisitions, divestitures, financings, restructurings, and post-merger integration.

Mr. Gumm received his JD from the Northwestern University School of Law, where he served as an editor of the Northwestern University Law Review. Prior to joining Latham, Mr. Gumm was an associate at another leading international law firm.

Mr. Gumm’s experience includes advising:

  • Amplitude in its US$1.8 billion direct listing
  • Clarify Health in its acquisition of Embedded Healthcare
  • CooperCompanies in its acquisition of Cook Medical’s Reproductive Health business
  • Evernote in its acquisition by Bending Spoons
  • Headspace in its merger with Ginger to create Headspace Health
  • Imago BioSciences in its US$1.4 billion acquisition by Merck
  • John Deere in its US$250 million acquisition of Bear Flag Robotics
  • Revolution Medicines in its US$230 million follow-on public offering
  • Seres Therapeutics in its license agreement with Nestlé Health Science to jointly commercialize SER-109, Seres’ investigational oral microbiome therapeutic for recurrent Clostridium difficile infection (CDI), in the United States and Canada
  • Thumbtack in its US$275 million investment
  • The underwriters in HashiCorp’s US$1.2 billion initial public offering

Bar Qualification

  • California


  • JD, Northwestern University School of Law, 2017
    cum laude
  • MA in Philosophy, Colorado State University, 2013
  • BA in Philosophy, Grinnell College, 2011

Languages Spoken

  • English